Promus Capital’s Bio-Techne TECH Stock Holding History

Promus Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$5.86K	–	335
2025 Q1	$5.86K	Hold	100	–	–	﹤0.01%	264
2024 Q4	$7.2K	Buy	+100	New	+$7.34K	0.01%	255

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Promus Capital's TECH Position: Q2 2025 in Review

Promus Capital sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 100 shares — an estimated $5.86K sold.

Promus Capital first reported a position in TECH in Q4 2024 and held it in 2 quarters. The position peaked at $7.2K in Q4 2024. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Promus Capital reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Promus Capital sold 100 Bio-Techne shares in Q2 2025, an estimated $5.86K.
Promus Capital first reported a position in Bio-Techne in Q4 2024 and held it in 2 quarters.
Promus Capital's Bio-Techne position peaked at $7.2K in Q4 2024.
554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Promus Capital's 13F filing for Q2 2025, filed 14 Aug 2025.